4//SEC Filing
Virsik Peter 4
Accession 0001209191-24-002950
CIK 0001633932other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 11:29 AM ET
Size
9.0 KB
Accession
0001209191-24-002950
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Virsik Peter
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Shares
2024-02-06$3.23/sh+72,782$235,086→ 86,110 total - Sale
Common Shares
2024-02-06$10.29/sh−72,782$748,927→ 13,328 total - Exercise/Conversion
Options
2024-02-06−72,782→ 895,000 totalExercise: $3.23From: 2023-10-07Exp: 2029-10-07→ Common Shares (72,782 underlying)
Footnotes (2)
- [F1]Reflects a transaction effected pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001826322
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 11:29 AM ET
- Size
- 9.0 KB